FDA alerts health care providers of recall of anemia drug Omontys
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
Named Organic Reactions
Thomas Laue, Andreas Plagens – Named Organic Reactions (2nd edition) Named reactions still are an important element of organic chemistry,
Researchers identify first drug targets in childhood genetic tumor disorder.
[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving
Massachusetts General Hospital, AstraZeneca Partner to Create New Drug Combos.
[column]Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their
Acme Specialized Pharmaceuticals Limited
With over five decades of partnering life and engendering hope, ACME is one of the top leading pharmaceuticals company in
Interview: Masuma Anwar, Head of Quality Management Systems, Healthcare Pharmaceuticals Limited
[column]An International summit on ‘GMP (Good Manufacturing Practice) and GCP (Good Clinical Practice): USA, Europe, Japan, Asia Pacific’ was held